These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1916699)

  • 1. Mac387: its non-specificity as a tumour marker or marker of histiocytes.
    Loftus B; Loh LC; Curran B; Henry K; Leader M
    Histopathology; 1991 Sep; 19(3):251-5. PubMed ID: 1916699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.
    Leader M; Patel J; Collins M; Henry K
    Am J Surg Pathol; 1987 Feb; 11(2):133-9. PubMed ID: 2433954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.
    Cassidy M; Loftus B; Whelan A; Sabt B; Hickey D; Henry K; Leader M
    Virchows Arch; 1994; 424(6):635-40. PubMed ID: 7519954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin: an evaluation of its role as a tumour marker.
    Leader M; Collins M; Patel J; Henry K
    Histopathology; 1987 Jan; 11(1):63-72. PubMed ID: 2435649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
    Leader M; Collins M; Patel J; Henry K
    J Clin Pathol; 1986 Nov; 39(11):1186-92. PubMed ID: 3540015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Histiocytic markers" in melanoma.
    Pernick NL; DaSilva M; Gangi MD; Crissman J; Adsay V
    Mod Pathol; 1999 Nov; 12(11):1072-7. PubMed ID: 10574605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
    Binder SW; Said JW; Shintaku IP; Pinkus GS
    Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histiocytic marker PG-M1 is helpful in differentiating histiocytes and histiocytic tumors from melanomas.
    Groisman GM; Amar M; Schäfer I
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):205-9. PubMed ID: 12373144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA125 expression in epithelioid sarcoma.
    Kato H; Hatori M; Kokubun S; Watanabe M; Smith RA; Hotta T; Ogose A; Morita T; Murakami T; Aiba S
    Jpn J Clin Oncol; 2004 Mar; 34(3):149-54. PubMed ID: 15078911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas.
    Leader M; Patel J; Makin C; Henry K
    Histopathology; 1986 Dec; 10(12):1315-24. PubMed ID: 2434403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between metaplastic carcinomas and sarcomas of the human female breast by fibronectin.
    Christensen L; Nielsen M; Hølund B; Clemmensen I
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(4):465-76. PubMed ID: 2996215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases.
    Fisher C
    Histopathology; 1990 May; 16(5):441-54. PubMed ID: 1694515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue.
    Thompson SJ; Schatteman GC; Gown AM; Bothwell M
    Am J Clin Pathol; 1989 Oct; 92(4):415-23. PubMed ID: 2552791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
    Pinkus GS; Kurtin PJ
    Hum Pathol; 1985 Sep; 16(9):929-40. PubMed ID: 2993153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of markers in the diagnosis of soft tissue tumours.
    Roholl PJ; De Jong AS; Ramaekers FC
    Histopathology; 1985 Oct; 9(10):1019-35. PubMed ID: 4085978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
    Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
    J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC expression has limited utility in the distinction of undifferentiated radiation-associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma.
    Mito JK; Qian X; Jo VY; Doyle LA
    Histopathology; 2020 Oct; 77(4):667-672. PubMed ID: 32506510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
    Patel RM; Folpe AL
    Pathology; 2009; 41(6):527-32. PubMed ID: 19900100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.